Dr. William Foulkes, an award-winning clinician-researcher at the Lady Davis Institute, has been appointed JGH Director of Medical Genetics.
New book examines how Sheila Kussner and Hope & Cope forged a breakthrough in supporting cancer patients.
Virtual reality goggles, available from Hope & Cope volunteers, are now helping patients pass the time during lengthy chemotherapy sessions.
Anti-cancer treatment is now under way with a highly sophisticated and versatile linear accelerator that’s newly installed at the JGH.
As Dr. Denny Laporta eases into semi-retirement in Intensive Care, an award has been established in his honour.
Certain brain cells may be inherently vulnerable to mutations that cause fatal brain tumours in children, says a study co-led by an LDI researcher.
Dr. Emily Kay-Rivest has joined the JGH Department of Otolaryngology-Head and Neck Surgery as a specialist in ear and skull base surgery.
Although exercise is recognized as being good for cancer patients, hematologist Dr. Nathalie Johnson is taking a closer look at how it helps those with lymphoma.
Dr. Solon Schur has joined the JGH Division of Neurosurgery as a member of staff and as Assistant Professor of Neurosurgery.
A potential breakthrough in cancer treatment, using magnetism to guide medication-carrying bacteria into tumours, will be tested in a new JGH lab.